Clinical Trial Update: Trop2-targeted immunoPET Imaging of Solid Tumors [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for Trop2-targeted immunoPET imaging of solid tumors, currently in Phase 2/3 and recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Cervical Cancer
• Cholangiocarcinoma
• Hepatocellular Carcinoma
• Lung Cancer
• Nasopharyngeal Carcinoma
• Ovarian Cancer
• Prostate Cancer

Snippet

Sponsor: RenJi Hospital | Conditions: Solid Tumor, Solid Carcinoma | Phase 2, Phase 3 | Status: RECRUITING